Ying Liu

机构：Inner Mongolia University for Nationalities, Dalian Institute of Chemical Physics, Dalian Medical University, Affiliated Hospital of North Sichuan Medical College, Precision for Medicine (United States), First Affiliated Hospital of Dalian Medical University, Henan Cancer Hospital, Shijiazhuang Yiling Pharmaceutical (China), Beijing Tsinghua Chang Gung Hospital, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0002-9071-1310

发表论文 44 篇 · 总被引 1119 次 · h-index 17

代表论文

• Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy (2024 · Journal of Translational Medicine · 被引 74)
• Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With Microparticles (2021 · Frontiers in Immunology · 被引 58)
• Natural killer cells in the central nervous system (2023 · Cell Communication and Signaling · 被引 37)
• Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells (2023 · Journal of Medicinal Chemistry · 被引 28)
• Compound small peptide of Chinese medicine alleviates cyclophosphamide induced immunosuppression in mice by Th17/Treg and jejunum intestinal flora (2023 · Frontiers in Microbiology · 被引 20)
• Achyranthes bidentata polysaccharides improve cyclophosphamide-induced adverse reactions by regulating the balance of cytokines in helper T cells (2024 · International Journal of Biological Macromolecules · 被引 19)